4 岁儿童自闭症谱系障碍的早期识别 - 自闭症和发育障碍监测网络,11 个站点,美国,2018 年。

IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Kelly A Shaw, Matthew J Maenner, Amanda V Bakian, Deborah A Bilder, Maureen S Durkin, Sarah M Furnier, Michelle M Hughes, Mary Patrick, Karen Pierce, Angelica Salinas, Josephine Shenouda, Alison Vehorn, Zachary Warren, Walter Zahorodny, John N Constantino, Monica DiRienzo, Amy Esler, Robert T Fitzgerald, Andrea Grzybowski, Allison Hudson, Margaret H Spivey, Akilah Ali, Jennifer G Andrews, Thaer Baroud, Johanna Gutierrez, Libby Hallas, Jennifer Hall-Lande, Amy Hewitt, Li-Ching Lee, Maya Lopez, Kristen Clancy Mancilla, Dedria McArthur, Sydney Pettygrove, Jenny N Poynter, Yvette D Schwenk, Anita Washington, Susan Williams, Mary E Cogswell
{"title":"4 岁儿童自闭症谱系障碍的早期识别 - 自闭症和发育障碍监测网络,11 个站点,美国,2018 年。","authors":"Kelly A Shaw, Matthew J Maenner, Amanda V Bakian, Deborah A Bilder, Maureen S Durkin, Sarah M Furnier, Michelle M Hughes, Mary Patrick, Karen Pierce, Angelica Salinas, Josephine Shenouda, Alison Vehorn, Zachary Warren, Walter Zahorodny, John N Constantino, Monica DiRienzo, Amy Esler, Robert T Fitzgerald, Andrea Grzybowski, Allison Hudson, Margaret H Spivey, Akilah Ali, Jennifer G Andrews, Thaer Baroud, Johanna Gutierrez, Libby Hallas, Jennifer Hall-Lande, Amy Hewitt, Li-Ching Lee, Maya Lopez, Kristen Clancy Mancilla, Dedria McArthur, Sydney Pettygrove, Jenny N Poynter, Yvette D Schwenk, Anita Washington, Susan Williams, Mary E Cogswell","doi":"10.15585/mmwr.ss7010a1","DOIUrl":null,"url":null,"abstract":"<p><strong>Problem/condition: </strong>Autism spectrum disorder (ASD).</p><p><strong>Period covered: </strong>2018.</p><p><strong>Description of system: </strong>The Autism and Developmental Disabilities Monitoring Network is an active surveillance program that estimates ASD prevalence and monitors timing of ASD identification among children aged 4 and 8 years. This report focuses on children aged 4 years in 2018, who were born in 2014 and had a parent or guardian who lived in the surveillance area in one of 11 sites (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin) at any time during 2018. Children were classified as having ASD if they ever received 1) an ASD diagnostic statement (diagnosis) in an evaluation, 2) a special education classification of ASD (eligibility), or 3) an ASD International Classification of Diseases (ICD) code. Suspected ASD also was tracked among children aged 4 years. Children who did not meet the case definition for ASD were classified as having suspected ASD if their records contained a qualified professional's statement indicating a suspicion of ASD.</p><p><strong>Results: </strong>For 2018, the overall ASD prevalence was 17.0 per 1,000 (one in 59) children aged 4 years. Prevalence varied from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California. At every site, prevalence was higher among boys than girls, with an overall male-to-female prevalence ratio of 3.4. Prevalence of ASD among children aged 4 years was lower among non-Hispanic White (White) children (12.9 per 1,000) than among non-Hispanic Black (Black) children (16.6 per 1,000), Hispanic children (21.1 per 1,000), and Asian/Pacific Islander (A/PI) children (22.7 per 1,000). Among children aged 4 years with ASD and information on intellectual ability, 52% met the surveillance case definition of co-occurring intellectual disability (intelligence quotient ≤70 or an examiner's statement of intellectual disability documented in an evaluation). Of children aged 4 years with ASD, 72% had a first evaluation at age ≤36 months. Stratified by census-tract-level median household income (MHI) tertile, a lower percentage of children with ASD and intellectual disability was evaluated by age 36 months in the low MHI tertile (72%) than in the high MHI tertile (84%). Cumulative incidence of ASD diagnosis or eligibility received by age 48 months was 1.5 times as high among children aged 4 years (13.6 per 1,000 children born in 2014) as among those aged 8 years (8.9 per 1,000 children born in 2010). Across MHI tertiles, higher cumulative incidence of ASD diagnosis or eligibility received by age 48 months was associated with lower MHI. Suspected ASD prevalence was 2.6 per 1,000 children aged 4 years, meaning for every six children with ASD, one child had suspected ASD. The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was lower than ASD prevalence among children aged 8 years (23.0 per 1,000 children aged 8 years).</p><p><strong>Interpretation: </strong>Groups with historically lower prevalence of ASD (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD among children aged 4 years in 2018, suggesting progress in identification among these groups. However, a lower percentage of children with ASD and intellectual disability in the low MHI tertile were evaluated by age 36 months than in the high MHI group, indicating disparity in timely evaluation. Children aged 4 years had a higher cumulative incidence of diagnosis or eligibility by age 48 months compared with children aged 8 years, indicating improvement in early identification of ASD. The overall prevalence for children aged 4 years was less than children aged 8 years, even when prevalence of children suspected of having ASD by age 4 years is included. This finding suggests that many children identified after age 4 years do not have suspected ASD documented by age 48 months.</p><p><strong>Public health action: </strong>Children born in 2014 were more likely to be identified with ASD by age 48 months than children born in 2010, indicating increased early identification. However, ASD identification among children aged 4 years varied by site, suggesting opportunities to examine developmental screening and diagnostic practices that promote earlier identification. Children aged 4 years also were more likely to have co-occurring intellectual disability than children aged 8 years, suggesting that improvement in the early identification and evaluation of developmental concerns outside of cognitive impairments is still needed. Improving early identification of ASD could lead to earlier receipt of evidence-based interventions and potentially improve developmental outcomes.</p>","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"70 10","pages":"1-14"},"PeriodicalIF":37.3000,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639027/pdf/","citationCount":"0","resultStr":"{\"title\":\"Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018.\",\"authors\":\"Kelly A Shaw, Matthew J Maenner, Amanda V Bakian, Deborah A Bilder, Maureen S Durkin, Sarah M Furnier, Michelle M Hughes, Mary Patrick, Karen Pierce, Angelica Salinas, Josephine Shenouda, Alison Vehorn, Zachary Warren, Walter Zahorodny, John N Constantino, Monica DiRienzo, Amy Esler, Robert T Fitzgerald, Andrea Grzybowski, Allison Hudson, Margaret H Spivey, Akilah Ali, Jennifer G Andrews, Thaer Baroud, Johanna Gutierrez, Libby Hallas, Jennifer Hall-Lande, Amy Hewitt, Li-Ching Lee, Maya Lopez, Kristen Clancy Mancilla, Dedria McArthur, Sydney Pettygrove, Jenny N Poynter, Yvette D Schwenk, Anita Washington, Susan Williams, Mary E Cogswell\",\"doi\":\"10.15585/mmwr.ss7010a1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Problem/condition: </strong>Autism spectrum disorder (ASD).</p><p><strong>Period covered: </strong>2018.</p><p><strong>Description of system: </strong>The Autism and Developmental Disabilities Monitoring Network is an active surveillance program that estimates ASD prevalence and monitors timing of ASD identification among children aged 4 and 8 years. This report focuses on children aged 4 years in 2018, who were born in 2014 and had a parent or guardian who lived in the surveillance area in one of 11 sites (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin) at any time during 2018. Children were classified as having ASD if they ever received 1) an ASD diagnostic statement (diagnosis) in an evaluation, 2) a special education classification of ASD (eligibility), or 3) an ASD International Classification of Diseases (ICD) code. Suspected ASD also was tracked among children aged 4 years. Children who did not meet the case definition for ASD were classified as having suspected ASD if their records contained a qualified professional's statement indicating a suspicion of ASD.</p><p><strong>Results: </strong>For 2018, the overall ASD prevalence was 17.0 per 1,000 (one in 59) children aged 4 years. Prevalence varied from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California. At every site, prevalence was higher among boys than girls, with an overall male-to-female prevalence ratio of 3.4. Prevalence of ASD among children aged 4 years was lower among non-Hispanic White (White) children (12.9 per 1,000) than among non-Hispanic Black (Black) children (16.6 per 1,000), Hispanic children (21.1 per 1,000), and Asian/Pacific Islander (A/PI) children (22.7 per 1,000). Among children aged 4 years with ASD and information on intellectual ability, 52% met the surveillance case definition of co-occurring intellectual disability (intelligence quotient ≤70 or an examiner's statement of intellectual disability documented in an evaluation). Of children aged 4 years with ASD, 72% had a first evaluation at age ≤36 months. Stratified by census-tract-level median household income (MHI) tertile, a lower percentage of children with ASD and intellectual disability was evaluated by age 36 months in the low MHI tertile (72%) than in the high MHI tertile (84%). Cumulative incidence of ASD diagnosis or eligibility received by age 48 months was 1.5 times as high among children aged 4 years (13.6 per 1,000 children born in 2014) as among those aged 8 years (8.9 per 1,000 children born in 2010). Across MHI tertiles, higher cumulative incidence of ASD diagnosis or eligibility received by age 48 months was associated with lower MHI. Suspected ASD prevalence was 2.6 per 1,000 children aged 4 years, meaning for every six children with ASD, one child had suspected ASD. The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was lower than ASD prevalence among children aged 8 years (23.0 per 1,000 children aged 8 years).</p><p><strong>Interpretation: </strong>Groups with historically lower prevalence of ASD (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD among children aged 4 years in 2018, suggesting progress in identification among these groups. However, a lower percentage of children with ASD and intellectual disability in the low MHI tertile were evaluated by age 36 months than in the high MHI group, indicating disparity in timely evaluation. Children aged 4 years had a higher cumulative incidence of diagnosis or eligibility by age 48 months compared with children aged 8 years, indicating improvement in early identification of ASD. The overall prevalence for children aged 4 years was less than children aged 8 years, even when prevalence of children suspected of having ASD by age 4 years is included. This finding suggests that many children identified after age 4 years do not have suspected ASD documented by age 48 months.</p><p><strong>Public health action: </strong>Children born in 2014 were more likely to be identified with ASD by age 48 months than children born in 2010, indicating increased early identification. However, ASD identification among children aged 4 years varied by site, suggesting opportunities to examine developmental screening and diagnostic practices that promote earlier identification. Children aged 4 years also were more likely to have co-occurring intellectual disability than children aged 8 years, suggesting that improvement in the early identification and evaluation of developmental concerns outside of cognitive impairments is still needed. Improving early identification of ASD could lead to earlier receipt of evidence-based interventions and potentially improve developmental outcomes.</p>\",\"PeriodicalId\":48549,\"journal\":{\"name\":\"Mmwr Surveillance Summaries\",\"volume\":\"70 10\",\"pages\":\"1-14\"},\"PeriodicalIF\":37.3000,\"publicationDate\":\"2021-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639027/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mmwr Surveillance Summaries\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.15585/mmwr.ss7010a1\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mmwr Surveillance Summaries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15585/mmwr.ss7010a1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

问题/条件:自闭症谱系障碍 (ASD).覆盖时期:2018.系统描述:自闭症和发育障碍监测网络是一项积极的监测计划,旨在估算自闭症谱系障碍(ASD)的患病率,并监测 4 至 8 岁儿童中自闭症谱系障碍的识别时间。本报告重点关注 2018 年 4 岁的儿童,这些儿童出生于 2014 年,其父母或监护人在 2018 年的任何时间居住在 11 个站点(亚利桑那州、阿肯色州、加利福尼亚州、佐治亚州、马里兰州、明尼苏达州、密苏里州、新泽西州、田纳西州、犹他州和威斯康星州)之一的监测区域内。如果儿童曾在评估中获得 1) ASD 诊断声明(诊断),2) ASD 特殊教育分类(资格),或 3) ASD 国际疾病分类 (ICD) 代码,则被归类为 ASD 患儿。此外,还对 4 岁儿童中的疑似 ASD 进行了追踪。不符合 ASD 病例定义的儿童,如果其记录中包含合格专业人员的声明,表示怀疑患有 ASD,则被归类为疑似 ASD:2018 年,4 岁儿童中 ASD 的总体患病率为千分之 17.0(59 分之一)。流行率从犹他州的千分之 9.1 到加利福尼亚州的千分之 41.6 不等。在每个地区,男孩的患病率都高于女孩,男女患病率之比为 3.4。在 4 岁儿童中,非西班牙裔白人(White)儿童的 ASD 患病率(12.9‰)低于非西班牙裔黑人(Black)儿童(16.6‰)、西班牙裔儿童(21.1‰)和亚裔/太平洋岛民(A/PI)儿童(22.7‰)。在患有 ASD 且有智力信息的 4 岁儿童中,52% 的儿童符合并发智力残疾的监测病例定义(智商≤70 或评估中记录的检查者关于智力残疾的声明)。在患有 ASD 的 4 岁儿童中,72% 在≤36 个月时进行了首次评估。按人口普查区家庭收入中位数(MHI)三等分法进行分层,家庭收入中位数低的三等分法(72%)在 36 个月时接受评估的 ASD 和智障儿童比例低于家庭收入中位数高的三等分法(84%)。4 岁儿童在 48 个月前被诊断为 ASD 或符合 ASD 诊断条件的累计发生率(2014 年出生的儿童中每 1,000 人中有 13.6 人)是 8 岁儿童(2010 年出生的儿童中每 1,000 人中有 8.9 人)的 1.5 倍。在所有 MHI 分层中,ASD 诊断或 48 个月前获得资格的累计发生率越高,MHI 越低。每 1,000 名 4 岁儿童中有 2.6 名疑似 ASD 患儿,这意味着每 6 名 ASD 患儿中就有 1 名疑似 ASD 患儿。自闭症和疑似自闭症的合计患病率(每1000名4岁儿童中有19.7名)低于8岁儿童的自闭症患病率(每1000名8岁儿童中有23.0名):2018年,ASD患病率历来较低的群体(非白人和低MHI)在4岁儿童中的患病率和累计发病率较高,这表明这些群体在识别ASD方面取得了进展。然而,在低 MHI 三元组中,36 个月前接受评估的 ASD 和智障儿童比例低于高 MHI 组,表明在及时评估方面存在差异。与 8 岁儿童相比,4 岁儿童在 48 个月前被诊断或符合条件的累计发生率更高,这表明在早期识别 ASD 方面有所改进。4 岁儿童的总体发病率低于 8 岁儿童,即使将 4 岁前怀疑患有 ASD 的儿童的发病率计算在内也是如此。这一结果表明,许多在 4 岁之后被发现的儿童在 48 个月之前并没有疑似 ASD 的记录:与 2010 年出生的儿童相比,2014 年出生的儿童更有可能在 48 个月大之前被确认患有 ASD,这表明早期确认的可能性增加了。然而,4 岁儿童的 ASD 识别率因地区而异,这表明有机会对促进早期识别的发育筛查和诊断方法进行研究。与 8 岁儿童相比,4 岁儿童更有可能同时患有智力障碍,这表明在认知障碍以外的发育问题的早期识别和评估方面仍需改进。改善对自闭症的早期识别,可以使儿童更早地接受循证干预,并有可能改善发育结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018.

Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018.

Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018.

Problem/condition: Autism spectrum disorder (ASD).

Period covered: 2018.

Description of system: The Autism and Developmental Disabilities Monitoring Network is an active surveillance program that estimates ASD prevalence and monitors timing of ASD identification among children aged 4 and 8 years. This report focuses on children aged 4 years in 2018, who were born in 2014 and had a parent or guardian who lived in the surveillance area in one of 11 sites (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin) at any time during 2018. Children were classified as having ASD if they ever received 1) an ASD diagnostic statement (diagnosis) in an evaluation, 2) a special education classification of ASD (eligibility), or 3) an ASD International Classification of Diseases (ICD) code. Suspected ASD also was tracked among children aged 4 years. Children who did not meet the case definition for ASD were classified as having suspected ASD if their records contained a qualified professional's statement indicating a suspicion of ASD.

Results: For 2018, the overall ASD prevalence was 17.0 per 1,000 (one in 59) children aged 4 years. Prevalence varied from 9.1 per 1,000 in Utah to 41.6 per 1,000 in California. At every site, prevalence was higher among boys than girls, with an overall male-to-female prevalence ratio of 3.4. Prevalence of ASD among children aged 4 years was lower among non-Hispanic White (White) children (12.9 per 1,000) than among non-Hispanic Black (Black) children (16.6 per 1,000), Hispanic children (21.1 per 1,000), and Asian/Pacific Islander (A/PI) children (22.7 per 1,000). Among children aged 4 years with ASD and information on intellectual ability, 52% met the surveillance case definition of co-occurring intellectual disability (intelligence quotient ≤70 or an examiner's statement of intellectual disability documented in an evaluation). Of children aged 4 years with ASD, 72% had a first evaluation at age ≤36 months. Stratified by census-tract-level median household income (MHI) tertile, a lower percentage of children with ASD and intellectual disability was evaluated by age 36 months in the low MHI tertile (72%) than in the high MHI tertile (84%). Cumulative incidence of ASD diagnosis or eligibility received by age 48 months was 1.5 times as high among children aged 4 years (13.6 per 1,000 children born in 2014) as among those aged 8 years (8.9 per 1,000 children born in 2010). Across MHI tertiles, higher cumulative incidence of ASD diagnosis or eligibility received by age 48 months was associated with lower MHI. Suspected ASD prevalence was 2.6 per 1,000 children aged 4 years, meaning for every six children with ASD, one child had suspected ASD. The combined prevalence of ASD and suspected ASD (19.7 per 1,000 children aged 4 years) was lower than ASD prevalence among children aged 8 years (23.0 per 1,000 children aged 8 years).

Interpretation: Groups with historically lower prevalence of ASD (non-White and lower MHI) had higher prevalence and cumulative incidence of ASD among children aged 4 years in 2018, suggesting progress in identification among these groups. However, a lower percentage of children with ASD and intellectual disability in the low MHI tertile were evaluated by age 36 months than in the high MHI group, indicating disparity in timely evaluation. Children aged 4 years had a higher cumulative incidence of diagnosis or eligibility by age 48 months compared with children aged 8 years, indicating improvement in early identification of ASD. The overall prevalence for children aged 4 years was less than children aged 8 years, even when prevalence of children suspected of having ASD by age 4 years is included. This finding suggests that many children identified after age 4 years do not have suspected ASD documented by age 48 months.

Public health action: Children born in 2014 were more likely to be identified with ASD by age 48 months than children born in 2010, indicating increased early identification. However, ASD identification among children aged 4 years varied by site, suggesting opportunities to examine developmental screening and diagnostic practices that promote earlier identification. Children aged 4 years also were more likely to have co-occurring intellectual disability than children aged 8 years, suggesting that improvement in the early identification and evaluation of developmental concerns outside of cognitive impairments is still needed. Improving early identification of ASD could lead to earlier receipt of evidence-based interventions and potentially improve developmental outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Mmwr Surveillance Summaries
Mmwr Surveillance Summaries PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
60.50
自引率
1.20%
发文量
9
期刊介绍: The Morbidity and Mortality Weekly Report (MMWR) Series, produced by the Centers for Disease Control and Prevention (CDC), is commonly referred to as "the voice of CDC." Serving as the primary outlet for timely, reliable, authoritative, accurate, objective, and practical public health information and recommendations, the MMWR is a crucial publication. Its readership primarily includes physicians, nurses, public health practitioners, epidemiologists, scientists, researchers, educators, and laboratorians.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信